Palisade Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 23, 2022 16:30 ET
|
Palisade Bio, Inc.
Carlsbad, CA, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI)...
Cyrex Array 2 Provides Canadian Clinicians Cutting-Edge Technology for Accurate Assessment and Monitoring of Intestinal Barrier Function
July 13, 2016 10:30 ET
|
Cyrex Laboratories
PHOENIX, AZ--(Marketwired - July 13, 2016) - Cyrex Laboratories, a clinical laboratory specializing in functional immunology and autoimmunity, offers Array 2, an intestinal antigenic permeability...
Cyrex Array 2 Provides Clinicians Cutting-Edge Technology for Accurate Assessment and Monitoring of Intestinal Barrier Function
July 13, 2016 10:00 ET
|
Cyrex Laboratories
PHOENIX, AZ--(Marketwired - July 13, 2016) - Cyrex Laboratories, a clinical laboratory specializing in functional immunology and autoimmunity, offers Array 2, an intestinal antigenic permeability...